Litcius/Paper detail

Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

Silvia Bellando-Randone, Francesco Del Galdo, Gemma Lepri, Tünde Minier, Dörte Huscher, Daniel E. Fürst, Yannick Allanore, Oliver Distler, László Czirják, Cosimo Bruni, Serena Guiducci, Jérôme Avouac, Maurizio Cutolo, Vanessa Smith, Marco Matucci‐Cerinic

2021The Lancet Rheumatology143 citationsDOI

Topics & Concepts

MedicineScleroderma (fungus)RheumatismSystemic sclerodermaRheumatologyInternal medicineAnti-nuclear antibodyClinical endpointDermatologyPhysical therapyClinical trialAutoantibodyDermatomyositisPathologyImmunologyAntibodyInoculationSystemic Sclerosis and Related DiseasesInflammatory Myopathies and DermatomyositisSystemic Lupus Erythematosus Research